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a b s t r a c t
Pluripotent stem cells retain the property to self-renew and differentiate into all cell types under deﬁned
conditions. Among mouse embryonic stem cells (ESCs), which are pluripotent but heterogenous in gene
expression and morphology, an ESC population cultured in small molecule inhibitors of two kinases,
MAPK/ERK kinase (Mek) and Glycogen synthase kinase 3 (Gsk3), and leukemia inhibitory factor (Lif) (2i/
L) is considered to be naïve pluripotent with uniform pluripotent machinery operation. Though the gene
regulatory mechanism for the naïve pluripotency has been investigated in recent years, it is still not fully
elucidated. Here we show a novel signaling involved in the maintenance of naïve pluripotency. An AMP-
activated protein kinase (AMPK) activator, AICAR (5-Aminoimidazole-4-carboxamied-1-b-riboside)
blocked the differentiation of mouse naïve ESCs in the absence of 2i/L and maintained the naïve state.
AICAR with Lif condition induced an almost comparable level of naïve pluripotent gene expression in
mouse ESCs. Another AMPK activator, A769662, also showed similar effects. A p38 inhibitor, SB203580,
blocked the AMPK activation-elicited naïve state maintenance. On the other hand, p38 activation
partially mimicked the maintenance effects of AMPK activators, suggesting that p38 is one of the
functional downstream molecules to conduct the AMPK effects. Thus, AMPK pathway should be involved
in the molecular circuitry of naïve pluripotency in mouse ESCs. These ﬁndings would be a valuable clue to
further elucidate the molecular machinery of naïve pluripotency.
© 2018 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Mouse embryonic stem cells (mESCs) are derived from inner
cells mass (ICM) in pre-implantation embryo [1,2]. Culturing in two
small molecule inhibitors (2i) of kinases, Mek (MAPK (mitogen-
activated protein kinase)/ERK (extracellular signal-regulated ki-
nase) and GSK3 (glycogen synthase kinase 3) and leukemia inhib-
itory factor (Lif), mESCs can be retained at naïve state with a similar
pluripotency as ICM [3,4]. Naïve mESCs display small dome-shaped
colonies, uniform pluripotency marker expression with unique
gene expressions and epigenetic modiﬁcations and has the poten-
tial to form all types of somatic cell lineages [5e8]. Lif is the ﬁrst
deﬁned signal to maintain mESCs self-renewal for long-term cul-
ture [3,9]. However, mESCs in Lif alone are morphological and
transcriptional heterogeneous. Two small molecule inhibitors (2i)
of MEK and GSK3 have been reported to sustain robust ES cell self-
renewal and suppress differentiation [4]. Combination of Lif and 2i
promotes mESCs in stable naïve state. Upon Lif and 2i withdrawal,
naïve ESCs spontaneously exit from the naïve state without an
exogenous inducer [5]. Naïve state is deﬁned with speciﬁc tran-
scription factors. Essential general pluripotency transcription fac-
tors, Oct4 and Sox2, play a central role in the maintenance of
pluripotency but are not restricted to naïve state [5]. Naïve mESCs
have a speciﬁc network of pluripotency transcription factors con-
taining Oct4 and Sox2 together with Nanog, Esrrb, Tfcp2l1, Klf4 and
Klf2 that are regulated by Lif and GSK3 pathways [5].
Adenosine monophosphate (AMP)-activated protein kinase
(AMPK), a serine/threonine protein kinase, which is activated by
increased intracellular AMP or AMP/ATP (adenosine triphosphate)
ratio, plays an important role in mediating cellular energy ho-
meostasis. The AMPK pathway participates in many cellular pro-
cesses such as cytokine production, cell growth, lipid metabolism,
protein synthesis and autophagy [10,11]. AMPK signal has been
reported to be involved in mouse ESC pluripotency and reprog-
ramming [12e14], but still unclear in naïve pluripotency. Rela-
tionship between AMPK and the naïve pluripotency transcription
factor network is unknown.* Corresponding author.
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We have been investigating pluripotent stem cell differentiation
[15e19]. During our research, we occasionally found that under an
AMPK activator, AICAR (5-Aminoimidazole-4-carboxamide-1-b-
riboside) treatment, mESCs were resistant to differentiation. Then,
we further investigated the phenomenon.
In the present study, we show that AMPK activators, AICAR and
A769662, can maintain mESCs in naïve state even in the absent of
2i/L and activates the network of naïve pluripotency transcription
factors. Our data offer a new pathway, AMPK signaling, in regula-
tion of naïve pluripotency that provides new insights and clues for
the research of molecular mechanisms for naïve pluripotency.
2. Materials and methods
2.1. Cell culture
Feeder-free mouse embryonic stem cells (mESCs) carrying Rex1
promoter-driven GFPd2 gene (Rex1-GFP cells) were cultured on
0.1% gelatin-coated dishes in basal medium (GMEM (GIBCO) sup-
plemented with 10% Knockout™ Serum Replacement (GIBCO), 1%
fetal bovine serum (SAFC Biosciences), 0.1mM MEM non-essential
amino acids (GIBCO), 1mM sodium pyruvate (SIGMA), 0.1mM 2-
mercaptoethanol (GIBCO), penicillin/streptomycin supplemented
with 1000 U/mL Lif (Millipore) and two small molecule inhibitors
(2i) PD0325901 1 mM (SIGMA) and CHIR99021 3 mM (Tocris)) as
described previously [4,15]. Cells were passaged every 3 days by
dissociation with Accumax (Innovative Cell Technologies) and
replated at 3 104 cells/cm2 cell density. Medium was changed
every 2 days.
2.2. Treatment with AMPK activators
AICAR (WAKO) was dissolved in distilled water at 125mM
concentration. A769662 (ADooQ) was dissolved in dimethyl sulf-
oxide (DMSO) at 100mM concentration. Dissociated mESCs were
plated on gelatin-coated dishes in basal medium supplemented
with Lif, 2i, AICAR (ﬁnal 1e3mM) or A769662 (ﬁnal 100 mM) with
indicated combinations. Cells were passaged every 4e7 days. Me-
dium was changed every 2 days.
2.3. Immunostaining
Immunostaining was carried out as described previously [15]. In
brief, cells were ﬁxed in 4% paraformaldehyde for 15e20min, then
blocked with 2% non-fat dry milk (BD). Cells were incubated with
primary antibodies of indicated dilution (rabbit anti-Nanog anti-
body (RepoCell, 1:300), rabbit anti-Tfe3 antibody (Sigma, 1:300)),
overnight at 4 C. Secondary antibodies, anti-rabbit IgG antibodies
conjugatedwith Alexa488 or Alexa546 (Invitrogen), were diluted to
1:500, treated for 1 h at room temperature and then washed with
phosphate-buffered serine with Tween-20. Nuclei were stained
with DAPI.
2.4. Western blot analysis
Cells were lysed in Sample buffer solution with 2-
mercaptoethanol (ME) (Nacalai Tesque). Cell lysates were run on
Blot™ Gel (Invitrogen), followed by electrophoretic transfer onto
nitrocellulose membranes. Then they were treated for 30min in
Blocking One (Nacalai Tesque) and incubated overnight at 4 C with
primary antibodies for following targets: phosphorylated-AMPK
(Thr172, Cell Signaling (2531S) 1:1000), AMPK (Cell Signaling
(2532S), 1:1000), phosphorylated-p38 (Thr180/Tyr182, Cell
Signaling (9215S), 1:1000), p38 (Cell Signaling (9212S), 1:1000),
phosphorylated-Mapkapk2 (Thr334, Cell Signaling (3007S),
1:1000), Mapkapk2 (Cell Signaling (3042S), 1:1000), b-actin (Sigma
(A5441), 1:10000). Secondary antibodies were anti-mouse or rabbit
IgG antibodies-conjugated with Horseradish peroxidase (HRP) (Cell
Signaling, 1:3000e1:1000). After 2 h of room temperature incu-
bation, Immobilonwestern chemiluminescent substrate (Millipore)
was used for detection. All primary and secondary antibodies were
diluted in the Can Get Signal Immunoreaction Enhancer Solution
Kit (Toyobo).
2.5. Quantitative real-time PCR (qPCR)
Total RNA was isolated using the RNeasy Mini kit (QIAGEN) and
cDNA was reverse-transcribed from 1 mg of total RNA using Super-
Script III (Invitrogen). All qPCR reactions were performed in tripli-
cate of each sample obtained from at least 3 independent cultures
in SYBR Green Master Mix (Applied Biosystems). An endogenous
control GAPDH was used to normalize expression of mouse cells.
Primer sequences: GAPDH-forward (F): TGT GTC CGT CGT GGA TCT
GA; GAPDH-reverse (R): TTG CTG TTG AAG TCG CAG GAG; Rex1-F:
TCT TCT CTC AAT AGA GTG AGT GTG C; Rex1-R: GCT TTC TTC TGT
GTG CAG GA Oct3/4-F: GGA CAT GAA AGC CCT GCA GAA; Oct3/4-R:
GAC AGA TGG TGG TCT GGC TGA A; Nanog-F: GAA TTC TGG GAA
CGC CTC ATC; Nanog-R: CCT TGT CAG CCT CAG GAC TTG; Sox2-F:
AAC CGA TGC ACC GCT ACG A; Sox2-R: TGC TGC GTA GGA CAT GCT
G; Klf4-F: AGA CCA GAT GCA GTC ACA AGT C; Klf4-R: CCC AGT CAC
AGT GGT AAG GTT T; Klf2-F: CTA AAG GCG CAT CTG CGT A; Klf2-R:
TAG TGG CGG GTA AGC TCG T; Esrrb-F: AGA GAC CCT CTC CTA TTC
CCA C; Esrrb-R: TCT CCA TGG GTT CCA GAA ATG G; Tfcp2l1-F: CCA
GGA AAA GGC TAG AAC CCA T; Tfcp2l1-R: AGG TTC TCA GGT CTC
CAG ATC A.
2.6. Imaging analysis
Images were photographed with inverted microscope (Olympus
IX71) equipped with U-RFL-T (Olympus), or with LSM700 inverted
confocal microscope (Zeiss) equipped with 405 nm, 488 nm, and
556 nm lasers using 10 or 20 objective.
2.7. Statistical analysis
All experiments were performed at least 3 times independently.
Statistical analysis of data was performed by ANOVA followed by
Tukey's multiple comparison. p< 0.05 was considered signiﬁcant.
Error bars indicate mean± SD.
3. Result
3.1. AICAR maintains naïve morphology and protein expression
For live cell monitoring of naïve pluripotency, we used a mESC
line, Rex1-GFP cells, in which expression of destabilized GFP pro-
tein with a half-life of 2 h (h) is driven by endogenous Rex1 pro-
moter [20,21].
To evaluate whether AICAR possesses an ability to maintain
naïve pluripotency, we cultured mESC with combinations of Lif, 2i,
and AICAR in basal maintenance medium for 4 passages (Fig. 1).
Cells completely lost Rex1-GFP expression and differentiated in
basal medium alone. Lifþ2i condition uniformly induced Rex1-GFP-
positive (Rex1-GFPþ) dome-shaped naïve cell colonies. Lif alone
was not sufﬁcient to maintain naïve cell colonies with the
appearance of heterogenous cell morphology. AICAR alone showed
not complete but distinct appearance of Rex1-GFPþ naïve cell-like
colonies. Lif þ AICAR was almost complete for uniform naïve cell
colony appearance as well as Lifþ2i (Fig. 1A). In order to quantify
the naïve-speciﬁc marker Rex1-positive cells after 4 passages, we
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Fig. 1. AICAR maintains naïve state of mESCs. (A) Colony morphology. Rex1-GFPd2 cells were cultured in basal medium, Lifþ2i, Lif alone, AICAR alone, and Lif þ AICAR condition,
respectively after 4 passages. Scale bars: 200 mm. (B and C) FACS analysis and quantitative evaluation for Rex1-GFPþ cell appearance after 4 passages. Percentages of the
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used ﬂow cytometry to analyze the expression of Rex1. Whereas in
basal medium alone, almost all of cells became Rex1-GFP-negative
(negative control), Lifþ2i showed almost complete naïve mainte-
nance with more than 95% (98.3% ± 0.46%) of Rex1-GFPþ cells
(positive control). AICAR alone induced signiﬁcantly more Rex1-
GFPþ cells (78.9% ± 3.6%) than basal medium alone. Surprisingly,
Lif þ AICAR showed similar Rex1-GFPþ cell maintenance
(96.2% ± 0.92%) to those in Lifþ2i condition (Fig. 1B and C). Since
Rex1 is a speciﬁc naïve marker and is downregulated upon with-
drawal of 2i within 24 h from the onset of differentiation [22,23],
AICAR has the potential to antagonize the exit from naïve state.
We evaluated other features of naïve ESCs with immunostaining
of colonies. Nanog staining showed highly homogeneous nuclear
distribution in Lif þ AICAR as well as Lifþ2i condition compared to
Lif alone (Fig. 1D). A bHLH transcription factor, Tfe3, is reported that
its nuclear exclusion normally relates to loss of naïve state plurip-
otency [24]. Whereas clear cytoplasmic localization of Tfe3 was
observed in Lif alone condition, nuclear localization was mainly
observed in Lifþ2i and Lif þ AICAR (Fig. 1E). All these results indi-
cate that AICAR can contribute to maintain naïve state of mESCs
even in the absence of Lif and 2i.
3.2. AICAR activates the network of naïve pluripotency
Next we examined mRNA expressions of molecular network for
naïve pluripotency by qPCR. With AICAR alone treatment, various
naïve pluripotent genes, Rex1, Oct4, Nanog, Sox2, Klf4, Klf2, Esrrb,
and Tfcp2l1, were signiﬁcantly higher than basal condition (Fig. 2).
In Lif þ AICAR condition, all these genes except Klf2 and Tfcp2l1
were comparable or signiﬁcantly higher than those in Lifþ2i
condition. Tfcp2l1, which plays a central role in Lif/Stat3 axis and is
activated by Gsk3i [25,26], was at approximately 30% in ACAIR
alone and at 50% in Lif þ AICAR, respectively, compared to that in
Lifþ2i. Instead, Klf4 expression in Lif þ AICAR condition was
signiﬁcantly higher than that in Lifþ2i. Thus, AICAR can broadly
induce gene expression of core molecular network for naïve plu-
ripotency to comparable level of Lifþ2i. Strong induction in Klf4
with AICARmay suggest that Klf4 should be a direct downstream of
AICAR.
3.3. Another AMPK activator A769662 also maintains naïve state
To evaluate whether the maintenance of naïve pluripotency
with AICAR is the effect of AMPK activation or other AICAR effects,
we tested another AMPK activator, A769662 [27]. Whereas AICAR
activates AMPK by mimicking AMP and through acting on AMPK-a
subunit, A769662 activates AMPK through acting on AMPK-b sub-
unit, indicating that those two activators have distinct molecular
mechanisms. Western blot analysis for phosphorylated AMPK and
total AMPK in mESCs after AMPK activator treatments conﬁrmed
that AICAR and A769662 actually activated AMPK pathway
(Fig. 3A). Thenwe tested the effects of A769662 on themaintenance
of naïve pluripotency. We cultured naïve mESCs with combinations
of Lif, 2i, and A769662 in basal medium for 4 passages. A769662
alone sustained approximately 40% of Rex1þ cells which was
signiﬁcantly higher than basal medium. Lif þ A769662 maintained
more than 80% of Rex1þ cells which is comparable level with Lifþ2i
(Fig. 3B and C). Taken together A769662 also had the effect on
maintenance of naïve mESCs.
Fig. 2. AICAR activates naïve pluripotent factor expression in mESCs. qPCR showing mRNA expression of naïve markers. GAPDH was used as control. Mean ± SD of three in-
dependent experiments are shown. Results of Lifþ2i were set as 1 (*p < 0.05, **p < 0.01, ***p< 0.001, NS: not signiﬁcant).
GFPþ population (n ¼ 3; ***p < 0.001, NS: not signiﬁcant) are indicated. (D) Fluorescent immunostaining for Nanog expression in cells of culturing in Lif, Lif þ AICAR and Lifþ2i. Five
hundred cells were plated and stained for Nanog after 4days. Scale bars: 20 mm. (E) Fluorescent immunostaining for Tfe3 expression in maintained mESCs with Lif, Lif þ AICAR and
Lifþ2i. Scale bars: 20 mm.
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3.4. p38 is a downstream of AMPK for maintenance of naïve
pluripotency
AMPK has many downstream signaling pathways involved in
broad biological phenomena including metabolism, cell growth,
autophagy and so on [11,28,29]. Among them, p38 is reported to be
activated by AMPK pathway [29] and also involved in reprogram-
ming of somatic cells to pluripotent stem cells [30]. Then, we
speculated that p38 should be a potential downstream involved in
the AMPK-elicited maintenance of naïve pluripotency. We
conﬁrmed that AICAR or A769662 can activate p38 with western
blot for phosphorylation of p38 as well as that of a p38 target
molecule, mapkapk2 (Fig. 4A). Then, we examined the effects of a
p38 inhibitor, SB203580 on AMPK activators-induced naïve state
maintenance. Flow cytometry analysis for Rex1-GFP revealed that
SB203580 reduced Rex1-GFPþ cells under basal medium with
AICAR or A769662 treatment (Fig. 4B and C). We further conﬁrmed
a gain-of-function effect of p38. We generated a mESC line carrying
tetracycline-inducible (Tet-ON) constitutive active form of p38 (CA-
p38) [30]. A p38 cDNA containing D176A and F327S mutations [31]
was inserted into a piggyBac (PB) vector carrying rtTA expression
coupled to mCherry [32]. We introduced the Tet-On CA-p38 with
mCherry gene into Rex1-GFPd2 cell line. Dox treatment (Doxþ)
actually induced p38 activation, conﬁrmed by phosphorylation of
p38 and mapkapk2 (Fig. 4D). p38 activation with Dox alone was
able to induce Rex1-GFPþ cell appearance. p38 activation with Lif
further enhanced the effect of Lif alone on Rex1-GFPþ cell main-
tenance (Fig. 4E), though effect of p38 activation on the mainte-
nance of naïve pluripotency was weaker than that of AICAR or
A769662. All these results suggest that p38 is one of the functional
downstream molecules conducting the AMPK effect on the main-
tenance of naïve pluripotency.
Fig. 3. AMPK activators maintain naïve state of mESCs. (A) AMPK activation. Western blot analysis shows protein expression of AMPKa and phosphorylated AMPKa (Thr172) by
AMPK activators. (B and C) FACS analysis and quantitative evaluation for Rex1-GFPþ cell appearance. Rex1-GFPd2 cells were cultured in basal medium with Lif þ A769662 and
A769662 after 4 passages. Percentages of the GFPþ population (n ¼ 3; *p < 0.05, ***p< 0.001, NS: not signiﬁcant) are indicated.
Y. Liu, J.K. Yamashita / Biochemical and Biophysical Research Communications 509 (2019) 24e3128
Fig. 4. p38 is a functional downstream of AMPK. (A) p38 activation with AMPK activators. Western blot analysis shows protein expression of p38, phosphorylated p38 (Thr180/
Tyr182), a unique p38 downstream target mapkapk2 and phosphorylated mapkapk2 (Thr334). Note that p38 is activated commonly with AMPK activators. (B and C) FACS analysis
for Rex1-GFPþcell appearance with a p38 inhibitor. p38i: SB203580 (10 mM). (D) Tetracycline-inducible (Tet-ON) constitutive active form of p38 (CA-p38) expression marked with
mCherry. Western blot conﬁrms dox-inducible activation of p38 pathway with CA-p38 expression. Doxycycline (1 mg/ml) treatment. (E) FACS analysis for Rex1-GFPþcell appearance
after p38 activation.
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4. Discussion
Here we showed that AMPK activators contribute to maintain
naïve pluripotency in mESCs. AMPK activators are capable of acti-
vating the molecular network of naïve pluripotency in mESCs. p38
is revealed to be one of the possible downstream of AMPK signaling
for the maintenance of naïve pluripotency.
Two distinct AMPK activators showed similar effects on the
maintenance of naïve pluripotency. AICAR is an AMP analog that
can mimic the endogenous AMP inducing activation of AMPK
pathway [28]. A769662 directly activates AMPK pathway by
mimicking both effects of allosteric activation and inhibition of
dephosphorylation which is different from AICAR [27]. Both of
compounds similarly induced AMPK phosphorylation and p38
activation, leading to the similar maintenance effects of naïve
pluripotency, indicating that AMPK pathway is involved in the
maintenance of naïve pluripotency. Nevertheless, relationship be-
tween AMPK and the pluripotency transcription factor network is
still unclear. AICAR induced expression of naïve markers Rex1,
Nanog, Klf4, Klf2, Esrrb and Tfcp2l1 (Fig. 3). Especially, Klf4, which
is a direct target of Lif/Stat3 axis and has been reported that forced
expression lead to mESCs self-renewal [33], was upregulated
signiﬁcantly by AICAR, suggesting that one of the targets of AICAR
for the maintenance of naïve state is Klf4 signaling. On the other
hand, Tfcp2l1, another target of Lif/Stat3, was not sufﬁciently
upregulated asmuch as Klf4, suggesting that AMPK does not simply
mediate Lif/Stat3 signaling. Klf2, which is directly repressed by Tcf3
thereby activated by GSK3i [5], was not upregulated as obviously as
Klf4. Esrrb which is also a pivotal target of the Gsk3/Tcf3 axis [34]
was induced not signiﬁcantly as Klf4, suggesting that the effect of
AICAR in naïvemaintenance is not mediated by Gsk3/Tcf3 pathway.
Thus, activation of naïve pluripotency by AMPK activators should
be mediated by a new signaling independent on Lif and Gsk3.
AMPK pathway is one of the central regulators for controlling
cell polarity, migration, cytoskeletal dynamics andmetabolism [11].
AMPK was shown to play an important role in the activation of the
p38 pathway in the ischemic heart [29] and activation of p38 was
reported to induce the expression of some pluripotent genes for
promoting somatic cells reprogramming [30]. p38 inhibitor blocked
the AICAR-elicited maintenance of naïve state and p38 activation
partially induced naïve maintenance (Fig. 4), suggesting that p38
pathway is at least one of the functional downstream of AMPK.
Since the AMPK-mTOR pathway was reported to be involved in
reprogramming mouse somatic cells to induced pluripotent stem
cells (iPSCs) through autophagy [14], it is assumed that mTOR
might be the downstream of AMPK in the modulation of naïve
pluripotency. Meanwhile, AMPK activators results in increasing
NADþ levels and the NADþ/NADH ratio which leads to Sirt 1 acti-
vation [35]. Sirt 1 was reported to deacetylate Oct4, which pro-
moted the maintenance of naïve pluripotency [36]. Molecular
mechanism of AMPK pathway for the maintenance of naïve plu-
ripotency including these molecules should be further elucidated.
Collectively, this study offers a new molecular pathway that
contributes to the maintenance of naïve pluripotency in mouse
ESCs, providing us new insights and clues for elucidation of the
molecular machinery for naïve stem cell status.
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